Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. UK Injectables Market Outlook to 2017
     3.1 Current and Future Market Analysis
            3.1.1 By Top 10 Injectables
            3.1.2 By Top 10 Therapeutics
            3.1.3 By Major Players

4. Drivers and Challenges
     4.1 Drivers
     4.2 Challenges

5. Regulatory Environment

6. Competitive Landscape
     6.1 Novo Nordisk
            6.1.1 Business Overview
            6.1.2 Key Injectable Sales
            6.1.3 Strengths and Weaknesses
            6.1.4 Recent Developments
     6.2 Sanofi
            6.2.1 Business Overview
            6.2.2 Key Injectable Sales
            6.2.3 Strengths and Weaknesses
            6.2.4 Recent Developments
     6.3 Eli Lily & Co.
            6.3.1 Business Overview
            6.3.2 Key Injectable Sales
            6.3.3 Strengths and Weaknesses
     6.4 Pfizer
            6.4.1 Business Overview
            6.4.2 Key Injectable Sales
            6.4.3 Strengths and Weaknesses
            6.4.4 Recent Developments
     6.5 Abbott Laboratories
            6.5.1 Business Overview
            6.5.2 Key Injectable Sales
            6.5.3 Strengths and Weaknesses
            6.5.4 Recent Developments
     6.6 Takeda Pharmaceutical Company Ltd
            6.6.1 Business Overview
            6.6.2 Key Injectable Sales
            6.6.3 Strengths and Weaknesses
            6.6.4 Recent Developments